Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Efficient regulatory pathways and strong intellectual property protections also support ongoing product innovation and availability
See the lot record before procurement
Victoza is a once-daily GLP-1 RA therapy for patients with type 2 diabetes Indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
Over 48 weeks, Retatrutide helped adults with obesity lose weight
V.et al (2010)
US$ 22.94
US$ 24.12
US$ 20.70
US$ 26.96
US$ 20.69
US$ 20.78
